Pacer Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,999
Closed -$416K 3566
2025
Q1
$416K Buy
27,999
+807
+3% +$12K ﹤0.01% 1518
2024
Q4
$360K Buy
27,192
+135
+0.5% +$1.79K ﹤0.01% 1698
2024
Q3
$385K Sell
27,057
-865
-3% -$12.3K ﹤0.01% 1695
2024
Q2
$361K Sell
27,922
-560
-2% -$7.25K ﹤0.01% 1663
2024
Q1
$396K Sell
28,482
-284
-1% -$3.95K ﹤0.01% 1629
2023
Q4
$410K Sell
28,766
-897,979
-97% -$12.8M ﹤0.01% 1602
2023
Q3
$14.3M Buy
926,745
+29,211
+3% +$452K 0.05% 276
2023
Q2
$14.1M Sell
897,534
-679,335
-43% -$10.7M 0.06% 295
2023
Q1
$26M Buy
1,576,869
+550,572
+54% +$9.07M 0.11% 186
2022
Q4
$16M Sell
1,026,297
-61,285
-6% -$956K 0.08% 196
2022
Q3
$14.1M Buy
1,087,582
+241,326
+29% +$3.13M 0.1% 159
2022
Q2
$11.9M Buy
846,256
+419,798
+98% +$5.89M 0.09% 197
2022
Q1
$6.11M Buy
426,458
+160,896
+61% +$2.3M 0.05% 379
2021
Q4
$3.62M Buy
265,562
+109,095
+70% +$1.49M 0.04% 585
2021
Q3
$2.56M Sell
156,467
-1,823
-1% -$29.9K 0.03% 610
2021
Q2
$2.66M Buy
158,290
+26,164
+20% +$440K 0.04% 529
2021
Q1
$2.41M Sell
132,126
-7,185
-5% -$131K 0.04% 456
2020
Q4
$2.54M Buy
139,311
+107,435
+337% +$1.95M 0.05% 384
2020
Q3
$569K Buy
+31,876
New +$569K 0.01% 950
2020
Q1
Sell
-24,123
Closed -$476K 1068
2019
Q4
$476K Buy
24,123
+7,100
+42% +$140K 0.02% 796
2019
Q3
$293K Buy
17,023
+6,091
+56% +$105K 0.01% 1071
2019
Q2
$193K Sell
10,932
-82,373
-88% -$1.45M ﹤0.01% 1058
2019
Q1
$1.9M Sell
93,305
-1,887
-2% -$38.4K 0.05% 307
2018
Q4
$1.6M Sell
95,192
-14,720
-13% -$248K 0.06% 64
2018
Q3
$2.35M Buy
109,912
+9,691
+10% +$207K 0.09% 263
2018
Q2
$2.09M Buy
+100,221
New +$2.09M 0.09% 252